Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study

NCT00214734 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT00214734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Lead sponsor
Baxalta now part of Shire
Phase
Observational
Overall status
Completed
Start date
October 14, 2004
Completion date
March 2, 2007
Enrollment
108 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a